Modifying effects of morin on the development of aberrant crypt foci and bacterial enzymes in experimental colon cancer

Food and Chemical Toxicology

Volumn 47, Issue 2, 2009, Pages 309-315

  Karthik kumar, V ^a   Vennila, S ^a   Nalini, N ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

ACF; Bacterial enzymes; Colon cancer; DMH

Indexed keywords

1,2 DIMETHYLHYDRAZINE; BACTERIAL ENZYME; BETA GALACTOSIDASE; BETA GLUCURONIDASE; CARCINOGEN; HYALURONIDASE; MORIN; NITROREDUCTASE; SULFATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CANCER INCIDENCE; CANCER PREVENTION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXPERIMENTAL NEOPLASM; INTESTINE CRYPT; MALE; NONHUMAN; RAT;

1,2-DIMETHYLHYDRAZINE; ANIMALS; ANTIOXIDANTS; BETA-GLUCOSIDASE; CARCINOGENS; COLON; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FLAVONOIDS; GLUCURONIDASE; INTESTINAL MUCOSA; MALE; NITROREDUCTASES; POLYSACCHARIDE-LYASES; PRECANCEROUS CONDITIONS; RATS; RATS, WISTAR;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 58149496090     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2008.11.017     Document Type: Article

References (51)

1. Arimochi H., Kataoka K., Kuwahara T., Nakayama H., Misawa N., and Ohnishi Y. Effects of β-glucuronidase-deficient and lycopene-producing Escherichia coli strains on formation of azoxymethane-induced aberrant crypt foci in the rat colon. Biochemical and Biophysical Research Communications 262 (1999) 322-327
2. Bauer H.G., Asp N.G., Oste R., Dahlqvist A., and Fredlund P.E. Effect of dietary fiber on the introduction of colorectal tumors and fecal β-glucuronidase activity in the rat. Cancer Research 59 (1979) 3752-3756
3. Bird R.P., and Good C.K. The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicology Letters 112-113 (2000) 395-402
4. Bratton A.C., and Marshall E.K. A new coupling component for sulfanilamide determination. The Journal of Biological Chemistry 128 (1939) 537-550
5. Brown J., O'Prey J., and Harrison PR. Enhanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways. Carcinogenesis 24 (2003) 171-177
6. Chao A., Thun M.J., Connell C.J., McCullough M.L., Jacobs E.J., Flanders W.D., Rodriguez C., Sinha R., and Calle E.E. Meat consumption and risk of colorectal cancer. JAMA 293 (2005) 172-182
7. Chipman J.K. Bile as a source of potential reactive metabolites. Toxicology 25 (1982) 99-111
8. Choa P.D.L., Hsiu S.L., and Hou Y.C. Flavonoids in herbs: biological fate and potential interaction with xenobiotics. Journal of Food and Drug Analysis 11 (2002) 135-145
9. Choudhary G., and Hansen H. Human health perspective on environmental exposure to hydrazines: a review. Chemosphere 37 (1998) 801-843
10. Denda A., Ura H., Tsujiuchi T., Tsutsumi M., Eimoto H., Takashima Y., Kitazawa S., Kinusaga T., and Konishi Y. Possible involvement of arachidonic acid metabolism in phenobarbital promotion of hepatocarcinogenesis. Carcinogenesis 10 (1989) 1929-1935
11. Facchini V., and Griffiths L.A. The involvement of the gastrointestinal microflora in nitrocompound-induced metahemoglobinaemia in rats and its relationship to nitrogroup reduction. Biochemical Pharmacology 30 (1981) 931-935
12. Fearon E.R., and Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767
13. Fenoglio-Preiser C.M., and Noffsinger A. Aberrant crypt foci: a review. Toxicologic Pathology 51 (1999) 5270-5274
14. Freeman H.J. Effects of differing purified cellulose, pectin, and hemicellulose fiber diet on fecal enzymes in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Cancer Research 46 (1986) 5529-5532
15. Goldin B.R., and Gorbach S.L. Effect of Lactobacillus acidophilus dietary supplementation on 1,2-dimethylhydrazine dihydrochloride induced intestinal cancer in rats. Journal of the National Cancer Institute 64 (1980) 263-265
16. Goldin B.R., and Gorbach S.L. Alterations of the intestinal microflora by diet, oral antibiotics and Lactobacillus: decreased production of free amines from aromatic nitro compounds, azo dyes and glucuronides. Journal of the National Cancer Institute 73 (1984) 689-695
17. Hertog M.G.L., Hollman P.C.H., Katan M.B., and Kromhourt D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutrition and Cancer 20 (1993) 21-29
18. Iwase Y., Takemura Y., Juichi M., Mukainaka T., Ichiishi E., Ito C., et al. Inhibitory effect of flavonoid derivatives on Epstein-Barr virus activation and two-stage carcinogenesis of skin tumors. Cancer Letters 173 (2001) 105-109
19. Johnson J.J., and Mukhtar H. Curcumin for chemoprevention of colon cancer. Cancer Letters 255 (2007) 170-181
20. Kyle J.W., Galvin N., Vogler C., and Grubb J.H. GUS (beta-glucuronidase) assay in animal tissue. In: Gallagher S.R. (Ed). GUS Protocols: Using the Beta-Glucuronidase Gene as a Reporter of Gene Expression (1992), Academic Press, San Diego 189-203
21. Lowry O.H., Rosebrough J.J., Farr A.L., and Randall R.J. Protein measurements with Folin phenol reagent. Journal of Biological Chemistry 193 (1951) 265-275
22. Morimitsu Y., Sugihara N., and Furuno K. Inhibitory effect of Flavonoids on Sulfo- and Glucurono-conjugation of acetaminophen in rat cultured hepatocytes and liver subcellular preparations. Biological and Pharmaceutical Bulletin 27 (2004) 714-717
23. Murdter T.E., Sperker B., Kivisto K.T., McClellan M., Fritz P., Friedel G., Linder A., Bosslet K., Toomes H., Dierkesmann R., and Kroemer H.K. Enhanced uptake of doxorubicin into bronchial carcinoma: beta-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Cancer Research 57 (1997) 2440-2445
24. Nelson N. A photometric adaptation of the Somogyi method for the determination of glucose. Journal Biological Chemistry 153 (1944) 375-380
25. Nemeth K., Plumb G.N., Berrin J.-G., et al. Deglycosylation by small intestinal epithelial cell -glucosidases is a critical step in the absorption and metabolism of dietary flavonoid glycosides in humans. European Journal of Nutrition 42 (2003) 29-42
26. Onoue M., Kado S., Sakaitani Y., Uchida K., and Morotomi M. Specific species of intestinal bacteria influence the induction of aberrant crypt foci by 1,2-dimethylhydrazine in rats. Cancer Letters 113 (1997) 179-186
27. Reddy B.S., and Wynder E.L. Large-bowel carcinogenesis: fecal constitution of populations with diverse incidence rates of colon cancer. Journal of the National Cancer Institute 50 (1973) 1437-1442
28. Reddy B.S., Weisburger J.H., and Wynder E.L. Fecal bacterial β-glucuronidase: control by diet. Science 183 (1974) 416-417 (Washington, DC)
29. Reddy B.S., Narisawa T., Weisburger J.H., and Wynder E.L. Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. Journal of the National Cancer Institute 56 (1976) 441-442
30. Reddy B.S., Mortin C.W., and Wynder E.L. Roles of endogenous substances and bacteria in colorectal cancer. Mutation Research 290 (1977) 71-78
31. Reddy B.S., Mangat S., Weisburger J.H., and Wynder E.L. Effect of high-risk diets for colon carcinogenesis on intestinal mucosal and bacterial β-glucuronidase activity in F344 rats. Cancer Research 37 (1977) 3533-3536
32. Reddy B.S., Engle A., Simi B., and Goldman M. Effects of dietary fiber on colonic bacterial enzymes and bile acids in relation to colon cancer. Gastroenterology 102 (1992) 1475-1482
33. Rod T.O., and Midtvedt. Origin of intestinal β-glucuronidase in germfree, monocontaminated and conventional rats. Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section B, Microbiology 85 (1977) 271-276
34. Rogers A.E., Zeisel S., and Grooman J. Diet and carcinogenesis. Carcinogenesis 14 (1993) 2205-2217
35. Rowland I.R. Toxicology of the colon: role of the intestinal microflora. In: Gibson G.R., and McFarlane G.T. (Eds). Human Colonic Bacteria, Role in Nutrition, Physiology and Pathology (1995), CRC Press, Boca Raton, FL 155-174
36. Rowland I.R., Mallett A.K., and Wise A. A comparison of the activity of five microbial enzymes in cecal content from rats, mice, and hamsters, and response to dietary pectin. Toxicology and Applied pharmacology 64 (1983) 143-148
37. Sequeira J.L., Kobayasi S.S., and Rodrigues M.A. Early and late effects of wound healing on development of colon tumours in a model of colon carcinogenesis by 1,2-dimethylhydrazine in the rat. Pathology 32 (2000) 250-252
38. Shiau S.Y., and Chang G.W. Effects of dietary fiber on fecal mucinase and β-glucuronidase activity in rats. Journal of Nutrition 113 (1983) 138-144
39. Shiau S.Y., and Ong Y.O. Effects of cellulose, agar and their mixture on colonic mucin degradation in rats. Journal of Nutritional Science and Vitaminology 38 (1992) 49-55
40. Simson G.L., and Gorbach S.L. Intestinal flora in health and disease. Gastroenterology 86 (1984) 174-193
41. Starvic B. Role of chemopreventers in human diet. Clinical Biochemistry 27 (1994) 319-332
42. Takada H., Hirooka T., Hiramatsu Y., and Yamamoto M. Effect of β-glucuronidase inhibitor on azoxymethane-induced colonic carcinogenesis in rats. Cancer Research 42 (1982) 33l-334
43. Takayama T., Katsuki S., Takahashi Y., Ohi M., Nojiri S., Sakamaki S., Kato J., Kogawa K., Miyake H., and Niitsu Y. Aberrant crypt foci of the colon as precursors of adenoma and cancer. New England Journal of Medicine 339 (1998) 1277-1284
44. Tanaka T., Kawabata K., Kakumoto M., et al. Citrus auraptene inhibits chemically induced colonic aberrant crypt foci in male F344 rats. Carcinogenesis 18 (1997) 155-2161
45. Tanaka T., Kawabata K., Honjo S., Kohno H., Murakami M., Shimada R., Matsunaga K., Yamada Y., and Shimizu M. Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin. Oncology Reports 6 (1999) 1333-1340
46. Tanaka T., Kawabata K., Kakumoto M., Makita H., Ushida J., Honjo S., Hara A., Tsuda H., and Mori H. Modifying effects of a flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. Carcinogenesis 20 (1999) 1477-1484
47. Wargovich M.J., Chen C.D., Harris C., Yang E., and Velasco M. Inhibiton of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in the rat colon. International Journal of Cancer 60 (1995) 515-519
48. Wargovich, M. J., Chen, C. D., JimenezSteele, V. E., Velasco, M., Stepens, C. L., Price, R., Gray, K., Kelloff, G. J., 1996. Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer epidemiology, biomarkers and prevention, vol. 5. A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, pp. 355-360.
49. Weisburger J.H. Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants and carotenoids. American Journal of Clinical Nutrition 53 (1991) 226s-237s
50. Winawer S.J., Flehinger B.J., Schottenfeld D., and Miller D.G. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy. Journal of the National Cancer Institute 85 (1993) 1311-1318
51. Zhang Y., Hendrich S., and Murphy P.A. Glucuronidase are the main isoflavone metabolites in women. Journal of Nutrition 133 (2003) 399-404